New cancer therapies are proving successful but, as Rob Cyran tells Richard Beales, they're pricey at over $100,000 a year. Eventually that'll bring a clash between payers and drugmakers.
from Reuters Video: Breakingviews http://ift.tt/1VZsDeW
via
IFTTT
No comments:
Post a Comment